Vol 7, No 2 (2022)
Review article
Published online: 2022-06-14

open access

Page views 4431
Article views/downloads 495
Get Citation

Connect on Social Media

Connect on Social Media

Critical considerations in management of patients with left ventricular assist device in an Emergency Department practice

Tomasz Kłosiewicz1, Mateusz Mazur2, Radosław Zalewski1, Roland Podlewski1, Witold Jurczyk1, Mateusz Puślecki13
Medical Research Journal 2022;7(2):170-175.

Abstract

In recent years, mechanical circulatory support has become an increasingly used treatment strategy for end-stage heart failure. Due to technological progress and higher availability of this therapy, the number of patients receiving left ventricular assist devices (LVAD) is increasing. A natural consequence of this is occurrence of complications related to this therapy. A patient presenting to an emergency department (ED) expects the highest level of care. Emergency department staff should have basic knowledge and skills to provide initial diagnostic and therapeutic interventions for patients with LVAD in life-threatening conditions. The most common reasons for patients with LVADs presenting to the ED are bleeding, heart rhythm disorders, stroke, or infections. This article aims to present the basic information that may be useful during the first medical contact in an emergency department. The authors have discussed the issue of diagnosis, and differences in laboratory findings and indicate where to best seek help. The article is dedicated to physicians, nurses, and paramedics working in emergency departments.

Article available in PDF format

View PDF Download PDF file

References

  1. Lloyd-Jones D, Adams RJ, Brown TM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation. 2010; 121(7): 948–954.
  2. van Riet EES, Hoes AW, Wagenaar KP, et al. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016; 18(3): 242–252.
  3. Jones NR, Roalfe AK, Adoki I, et al. Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis. Eur J Heart Fail. 2019; 21(11): 1306–1325.
  4. Gustafsson F, Rogers JG. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail. 2017; 19(5): 595–602.
  5. EUROMACS Report. http://www.euromacs.org/files/13/file/EUROMACS_NEWSLETTER_No_10.pdf (25.03.2022).
  6. Schweiger M, Vierecke J, Stiegler P, et al. Prehospital care of left ventricular assist device patients by emergency medical services. Prehosp Emerg Care. 2012; 16(4): 560–563.
  7. McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599–3726.
  8. Tainter CR, Braun OÖ, Teran F, et al. Emergency department visits among patients with left ventricular assist devices. Intern Emerg Med. 2018; 13(6): 907–913.
  9. Goebel M, Tainter C, Kahn C, et al. An urban 9-1-1 system's experience with left ventricular assist device patients. Prehosp Emerg Care. 2019; 23(4): 560–565.
  10. Zieliński T, Wspomaganie lewokomorowe – metoda o rosnącym znaczeniu w leczeniu zaawansowanej niewydolności serca. Kardiologia po dyplomie. 2018; 3. https://podyplomie.pl/kardiologia/30603,wspomaganie-lewokomorowe-metoda-o-rosnacym-znaczeniu-w-leczeniu-zaawansowanej-niewydolnosci-serca (25.03.2022).
  11. Hockstein MA. Continuous-flow left ventricular assist devices: Management in the emergency department. J Am Coll Emerg Physicians Open. 2020; 1(4): 362–370.
  12. Draper KV, Huang RJ, Gerson LB. GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. Gastrointest Endosc. 2014; 80(3): 435–446.e1.
  13. Peberdy MA, Gluck JA, Ornato JP, et al. American Heart Association Emergency Cardiovascular Care Committee, Council on Cardiopulmonary, Critical Care, Perioperative, and Resuscitation, Council on Cardiovascular Diseases in the Young, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology. Cardiopulmonary Resuscitation in Adults and Children With Mechanical Circulatory Support: A Scientific Statement From the American Heart Association. Circulation. 2017; 135(24): e1115–e1134.
  14. Kociol RD, Pang PS, Gheorghiade M, et al. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol. 2010; 56(14): 1071–1078.
  15. Ahmad T, Wang T, O'Brien EC, et al. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. JACC Heart Fail. 2015; 3(1): 30–39.
  16. Darling CE, Martindale JL, Hiestand BC, et al. An emergency medicine-focused summary of the HFSA/SAEM/ISHLT clinical consensus document on the emergency management of patients with ventricular assist devices. Acad Emerg Med. 2020; 27(7): 618–629.
  17. Feldman D, Pamboukian SV, Teuteberg JJ, et al. International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013; 32(2): 157–187.
  18. Howell AJ, Ashkanase JL, Laks JA, et al. Sustained ventricular fibrillation in a conscious pediatric LVAD patient. The Journal of Heart and Lung Transplantation. 2021; 40(4): S535–S536.
  19. Goldstein DJ, John R, Salerno C, et al. Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant. 2013; 32(7): 667–670.
  20. Mehra MR, Goldstein DJ, Uriel N, et al. MOMENTUM 3 Investigators. Two-Year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2018; 378(15): 1386–1395.
  21. Stulak JM, Lee D, Haft JW, et al. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device. J Heart Lung Transplant. 2014; 33(1): 60–64.
  22. Stern DR, Kazam J, Edwards P, et al. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg. 2010; 25(3): 352–356.
  23. Demirozu ZT, Radovancevic R, Hochman LF, et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2011; 30(8): 849–853.
  24. Malik S, Malik SA, Ulmer LL, et al. Gastrointestinal bleeding with left ventricular assist devices (LVAD): locating the leak and identifying outcomes. J Clin Gastroenterol. 2019; 53(5): e202–e207.
  25. Uriel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol. 2010; 56(15): 1207–1213.
  26. Kim JuH, Brophy DF, Shah KB. Continuous-Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding. Cardiol Clin. 2018; 36(4): 519–529.
  27. Dang G, Grayburn R, Lamb G, et al. Octreotide for the management of gastrointestinal bleeding in a patient with a heartware left ventricular assist device. Case Rep Cardiol. 2014; 2014: 826453.
  28. Gurvits GE, Fradkov E. Bleeding with the artificial heart: gastrointestinal hemorrhage in CF-LVAD patients. World J Gastroenterol. 2017; 23(22): 3945–3953.
  29. Frontera JA, Starling R, Cho SM, et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Heart Lung Transplant. 2017; 36(6): 673–683.
  30. Mabvuure NT, Rodrigues JN. External cardiac compression during cardiopulmonary resuscitation of patients with left ventricular assist devices. Interact Cardiovasc Thorac Surg. 2014; 19(2): 286–289.
  31. Shinar Z, Bellezzo J, Stahovich M, et al. Chest compressions may be safe in arresting patients with left ventricular assist devices (LVADs). Resuscitation. 2014; 85(5): 702–704.
  32. Yarboro LT, Bergin JD, Kennedy JLW, et al. Technique for minimizing and treating driveline infections. Ann Cardiothorac Surg. 2014; 3(6): 557–562.
  33. Pavlovic NV, Randell T, Madeira T, et al. Risk of left ventricular assist device driveline infection: A systematic literature review. Heart Lung. 2019; 48(2): 90–104.
  34. Bowles CT, Hards R, Wrightson N, et al. Algorithms to guide ambulance clinicians in the management of emergencies in patients with implanted rotary left ventricular assist devices. Emerg Med J. 2017; 34(12): 842–850.
  35. Bowles C. Left ventricular assist devices in the community. Perfusion. 2000; 15(4): 373–374.